Diagnostic anti-Phospholipase A2 (LP-PLA2) antibodies (anti-Phospholipase A2, anti-LP-PLA2) and diagnostic hapten-carrier conjugates BSA-Phospholipase A2 (LP-PLA2), OVA-Phospholipase A2 (LP-PLA2), KLH-Phospholipase A2 (LP-PLA2) antigens for Metabolic diseases LP-PLA2 detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Genemedi produces core diagnostic ingredients for test of Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) and related syndrome. GeneMedi offers paired anti-Phospholipase A2 (LP-PLA2) antibodies (monoclonal antibody, mab) and Phospholipase A2 (LP-PLA2 antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated, KLH-conjugated) for Metabolic diseases (atherosclerosis, hyperlipidemia, obesity, and diabetes) rapid test kit of Phospholipase A2 (LP-PLA2) testing in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. The carrier-coupled antigens of small molecules can act as immunogens.The phospholipase A2?(PLA2) family of proteins includes lipolytic enzymes that catalyze the hydrolysis of the ester bond at the?sn-2 position of phospholipids to yield free fatty acids and lysophospholipids. Each member of the phospholipase A2?family of enzymes serves a distinct role in generating active lipid metabolites that promote inflammatory metabolic diseases including atherosclerosis, hyperlipidemia, obesity, and diabetes.